Global sampling provider Bioplan USA Inc. announced the proposed issuance of a $65 million revolver, a $375 million first-lien term loan, and a $145 million second-lien term loan. Bioplan USA is being formed through the merger of Paris-based Bioplan (a subsidiary of Ileos) and New York-based Arcade (a subsidiary of Visant). We are assigning the company a corporate credit rating of 'B'. We also assigned issue-level and recovery ratings to the company's proposed debt. The stable outlook reflects our expectation that the company will achieve low- to mid-single-digit revenue growth in 2014 and 2015 and that leverage will remain above 5x in the intermediate term. NEW YORK (Standard&Poor's) Aug. 4, 2014--Standard&Poor's Ratings Services today assigned a
